The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of June 30, 2015 (80 FR 37273). The document announced the availability of additional draft and revised draft product-specific bioequivalence (BE) recommendations. The document was published with an incorrect table title and contents. This document corrects those errors.
Document
Product-Specific Bioequivalence Recommendations; Draft and Revised Draft Guidances for Industry; Availability; Correction
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of June 30, 2015 (80 FR 37273). The document announced the availability of ad...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 43782
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Product-Specific Bioequivalence Recommendations; Draft and Revised Draft Guidances for Industry; Availability; Correction,” thefederalregister.org (July 23, 2015), https://thefederalregister.org/documents/2015-18024/product-specific-bioequivalence-recommendations-draft-and-revised-draft-guidances-for-industry-availability-correction.